• Aleksandra E Zgierska, Cindy A Burzinski, Jennifer Cox, John Kloke, Janice Singles, Shilagh Mirgain, Aaron Stegner, Dane B Cook, and Miroslav Bačkonja.
• 1 Department of Family Medicine and Community Health, University of Wisconsin-Madison , School of Medicine and Public Health, Madison, WI.
• J Altern Complement Med. 2016 Aug 1; 22 (8): 610-20.

ObjectiveAlthough mindfulness meditation (MM) is increasingly used for chronic pain treatment, limited evidence supports its clinical application for opioid-treated chronic low back pain (CLBP). The goal of this study was to determine feasibility, acceptability, and safety of an MM-based intervention in patients with CLBP requiring daily opioid therapy.Design26-week pilot randomized controlled trial comparing MM-based intervention, combined with usual care, to usual care alone.SettingOutpatient.PatientsAdults with CLBP treated with ≥30 mg of morphine-equivalent dose (MED) per day for 3 months or longer.InterventionsTargeted MM-based intervention consisted of eight weekly 2-hour group sessions and home practice (30 minutes/d, 6 days/wk) during the study. "Usual care" for opioid-treated CLBP was provided to participants by their regular clinicians.Outcome MeasuresFeasibility and acceptability of the MM intervention were assessed by adherence to intervention protocol and treatment satisfaction among experimental participants. Safety was evaluated by inquiry about side effects/adverse events and opioid dose among all study participants.ResultsThirty-five participants enrolled during the 10-week recruitment period. The mean age (±standard deviation) was 51.8 ± 9.7 years; the patients were predominantly female, with substantial CLBP-related pain and disability, and treated with 148.3 ± 129.2 mg of MED per day. All participants completed baseline assessments; none missed both follow-up assessments or withdrew. Among experimental participants (n = 21), 19 attended 1 or more intervention sessions and 14 attended 4 or more. They reported, on average, 164.0 ± 122.1 minutes of formal practice per week during the 26-week study and 103.5 ± 111.5 minutes of brief, informal practice per week. Seventeen patients evaluated the intervention, indicating satisfaction; their qualitative responses described the course as useful for pain management (n = 10) and for improving pain coping skills (n = 8). No serious adverse events or safety concerns occurred among the study participants.ConclusionsMM-based intervention is feasible, acceptable, and safe in opioid-treated CLBP.

17 keywords...

hide…